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ABSTRACT 
Nasal obstruction or stuffy nose, is one of the commonest presenting complaints in otorhinolaryngology 
clinics. If defects of the nasal septum are excluded, most commonly the problem can be attributed to the 
dysfunction of the nasal turbinates, mostly the inferior turbinates. Although every person experiences some 
degree of turbinate dysfunction at some point in life, persistent dysfunction is also not uncommon, involving 
approximately 50% of the population. In the short-term, the cases respond well to medical line of 
management which mainly constitute the use of decongestants, but their prolong use is not indicated 
because of health reasons. Similarly, the other medicines used, have only short-term benefits; once the 
inferior turbinates undergo submucosal fibrosis, then they become incapable of decongestion with medical 
line of management and those chronic cases of nasal obstruction need to be managed by surgical therapies 
only. Over the years, many surgical procedures have been employed for turbinate reduction, but incidences 
of complications, recurrence etc. along with the cost-factor mean that still there is much to be achieved in the 
management of hypertrophied turbinates of nose. Ksharakarma is a popular procedure of chemical cautery 
in Ayurveda, which has been used for centuries as a minimal invasive procedure for reduction of enlarged 
tissues. This study has been conducted to manage nasal obstruction, termed as Nasapratinaha in Ayurveda, 
due to hypertrophied turbinates, by application of Ksharakarma with significant results.  
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INTRODUCTION
Nasal disorders are among the most troublesome 
and irritating problems. Owing to increased pollution, 
changed lifestyle, allergens etc. in today’s industrial world, 
the incidences of nasal disorders have increased rapidly. In 
the Ayurvedic classics detailed description of Nasa Rogas, i.e. 
diseases of nose are explained. ‘Nasapratinaha’ is one such, 
with clinical feature of nasal obstruction.1,2 Among the 
various causes of nasal obstruction, enlarged nasal 
turbinates, especially the inferior turbinate, is very 
common.3 This problem is faced by most of us and while the 
use of medical line of treatment has limitation for prolonged 
use because of health purpose, surgical approaches too have 
not only failed to achieve desired results in all cases, but are 
also surrounded by controversies.4 
‘Kshara Karma’ is a popular treatment modality in 
Ayurveda based on the property of Kshara by which body 
tissues or fleshy masses can be destroyed. Ayurvedic classics 
have considered Kshara to be superior to Shastras and 
Anushastras.5 Use of Kshara has been advocated in 
Nasaarsha and Nasaarbuda also.6 
Keeping in mind the above considerations, 
Ksharakarma has been deemed to be an effective remedy 
and hence employed for the management of nasal 
obstruction due to hypertrophy of inferior turbinates in my 
study. 
 
 
MATERIALS AND METHODS 
Aims and objectives of the study: To evaluate the effect 
of Ksharakarma in the management of nasal obstruction 
(Nasapratinaha) due to hypertrophied inferior turbinates. 
Source of data 
1. Patients: 20 Patients with clinical features of 
hypertrophied inferior turbinates were selected from the 
OPD and IPD of Govt. Ayurvedic College Hospital, 
Guwahati-14. 
2. Trial drug: Kshara was prepared from Apamarga plants 
collected from the nearby areas of Jalukbari. Drug 
selection, collection and subsequently preparation of 
Kshara was done strictly according to the guidelines of 
Sushruta Samhita. 
Diagnostic criteria: Patients were diagnosed on the basis 
of history, signs and symptoms of hypertrophied inferior 
turbinates. Inspection was done with Anterior Rhinoscopy, 
probing, cold spatula test and measurement of the size of 
the inferior turbinates. 
Inclusion criteria 
a. Patients diagnosed with nasal obstruction due to 
hypertrophied inferior turbinates. 
b. Age group: 15-60 years. 
c. Patients fit for application of Kshara. 
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Exclusion criteria 
a. Nasal obstruction due to any condition other than 
hypertrophied turbinates. 
b. Hypertrophied turbinates associated with systemic 
diseases. 
c. Hypertrophied turbinates associated with other 
inflammatory conditions of the nose. 
Assessment criteria 
 Patients were assessed with subjective and 
objective parameters formulated for Nasapratinaha due to 
hypertrophied inferior turbinates:- 
Subjective parameters: i. Nasal obstruction, ii. Nasal 
discharge, iii. Loss of smell perception, iv. Discomfort in 
nose, v. Headache & facial pain, vi. Congestion in nasal 
mucosa. 
Objective parameters: i. Anterior rhinoscopy, ii. Pictorial 
presentation, iii. X-ray PNS, iv. Size of inferior turbinates. 
Laboratory investigations: i. Routine blood test, ii. 
Random blood sugar, iii. Absolute eosinophilic count. 
Research design: 20 patients were selected for the study. 
A detailed history regarding the aetiological factors, 
personal habits, living status, occupation etc. were 
recorded. Diagnosis was confirmed by Anterior 
rhinoscopy, cold spatula test, probing and measurement of 
the inferior turbinates and aided with radiological 
findings. All the cases were documented in the clinical case 
sheets designed for the purpose.  
Method of Ksharakarma: Apamarga Kshara was 
prepared at the Rasashala of Govt. Ayurvedic College. 
Patients selected for the study were subjected to 
application of Kshara according to Trividh Karma- 
1. Poorvakarma: Patient was asked to come for treatment 
in empty stomach. Lidocaine 15% spray was sprayed into 
the nostrils to anaesthetize the turbinates in order to avoid 
sneezing reflex. Patient was placed in supine position with 
the head extended by placing a pillow under the shoulders 
or by adjustments in the dental chair to expose the nasal 
cavity properly; proper visualization was achieved using 
headlight or dental lamp. Nasal cavity was then properly 
cleaned with cotton piece soaked in normal saline. 
Posterior part of the nostril was packed with a gauze piece 
with the help of nasal packing forceps. An X-Ray plate of 
adequate size was cut and inserted into the nostril along 
the septum to prevent accidental injury to the septum by 
the Kshara application. 
2. Pradhan Karma: The nasal cavity was exposed using 
Thudichum Nasal Speculum and secretions over the 
turbinate were wiped out using gauze piece. Kshara was 
taken with Jobson probe rolled with cotton and was 
applied over the anterior (medial) surface of the exposed 
inferior turbinate. After 1-minute of administration the 
probe was withdrawn and the Kshara was wiped out. 
Lemon juice was applied over the treated turbinate to 
neutralize the remaining Kshara. Ghrita was applied over 
the burnt wound using the probe rolled with cotton. 
3. Paschat Karma: The X-Ray plate and posterior gauze 
packing were withdrawn. The patient was kept under 
vigilance for the next four hours with careful monitoring of 
vital data and changes in the clinical features. The patient 
then released with instructions to avoid exposure to hot 
and cold air or breeze, dust, smoke etc. and to take light 
food.  
Duration of the study: Patients were monitored for the 
changes caused due to Kshara application immediately 
after the application, and on 3rd, 7th, 15th and 21st days 
after the same. The effect of the treatment in terms of 
Subjective and Objective findings were observed and 
recorded on 1st day, 7th day and 21st day after the Kshara 
application in the proforma of Nasapratinaha designed for 
the clinical trial. These 21 days were considered as the 
duration of the treatment. Follow-up was done every 15 
days for the next 2 months. 
Criteria for assessment of treatment: Assessment of 
treatment were made before and after the treatment based 
on, 1. Nasal obstruction, 2. Nasal discharge, 3. Loss of Smell 
Perception, 4. Discomfort in Nose, 5. Congestion of Nasal 
Mucosa and Turbinates, 6. Headache, 7. X – Ray PNS, 8. Size 
of the Inferior turbinate- measured using compass-caliper 
having adjustable knob. 
OBSERVATION AND RESULTS 
Age: Age wise distribution of the patients showed that 
maximum number of patients (40%) belonged to the age 
group of 15-25 yrs, after which were 35-45 yrs group i.e. 
25% ,followed by the 25-35 yrs group with 15% patients 
and the age group of 45-60 yrs had the least contribution 
with 20%.  
Sex: Out of the 20 cases, incidence of hypertrophied 
inferior turbinates was observed in 15 male (75%) and 05 
female (25%) patients. 
Religion: 85% patients were Hindus, 10% were Muslims 
and 5% were Christians. 
Socio-economic status: Most subjects were from middle 
class (60%), followed by lower class (35%) and the upper 
class (5%). 
Habitat: Habitat wise distribution of the 20 patients 
showed that, 60% were residents of urban areas and 40% 
were from rural areas. 
Occupation: Out of the 40 Patients, 40% were students, 
20% were Housewives, 10% were agriculturists, 10% 
were teachers, and the groups of Govt/Private service, 
Businessman, Coolie and commercial drivers each 
contributed 5%. 
Diet: 11 patients were non-veg (55%) and 9 were veg 
(45%). 
Prakriti: Prakruti wise distribution showed that 45% 
were of Vatakaphaja, 35% Kaphapittaja, whereas rest 20% 
were of Vajapittaja prakruti. 
Nidanas: Distribution of Nidanas in the 20 patients 
showed that, 80% had Raja Sevana and Dhoom Sevana 
each, 50% had exposure to Avashyaya, 20% had 
Pratishyaya followed by the rest 10%, who had 
experienced Ambu Krida. 
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Table 1: Effects of Ksharakarma (immediately after application) 
Clinical features Mean % reduction 
in Mean score 
S.D. of 
Mean (±) 
S.E. of 
Mean(±) 
‘t’ value P value Remarks 
BT AT 
Nasal obstruction 3.1 1.85 40.32 0.44 0.1 12.5 <0.001 S 
Nasal discharge 1.95 1.5 23.10 0.68 0.15 3.0 <0.01 S 
Impairment of smell 1.3 0.9 30.77 0.5 0.11 3.63 <0.01 S 
Headache & Facial pain 0.8 0.7 12.50 0.79 0.18 0.56 >0.05 NS 
Discomfort in nose 2.2 2.0 09.09 0.89 0.2 1.0 >0.05 NS 
Congestion of nasal 
mucosa 
1.2 1.15 04.17 0.89 0.2 0.25 >0.05 NS 
Size of inferior turbinate 
(mm) 
3.4 2.2 35.29 0.41 0.09 13.33 <0.001 S 
Table 2: Effects of Ksharakarma (after 7 days of application) 
Clinical features Mean % reduction  
in Mean score 
S.D. of 
Mean (±) 
S.E. of 
Mean(±) 
‘t’ value P value Remarks 
BT AT 
Nasal obstruction 3.1 1.3 58.06 0.83 0.19 9.47 <0.001 S 
Nasal discharge 1.95 1.15 41.03 0.83 0.19 4.21 <0.001 S 
Impairment of smell 1.3 0.85 34.62 0.6 0.13 3.46 <0.01 S 
Headache & Facial pain 0.8 0.45 43.75 0.50 0.11 3.18 <0.01 S 
Discomfort in nose 2.2 1.1 50.00 1.07 0.24 4.58 <0.001 S 
Congestion of nasal mucosa 1.2 0.45 62.5 0.71 0.16 4.69 <0.001 S 
Size of inferior turbinate 
(mm) 
3.4 1.85 45.59 0.69 0.15 10.33 <0.001 S 
Table 3: Effects of Ksharakarma (after 21 days of application) 
Clinical features Mean % reduction in 
Mean score 
S.D. of 
Mean (±) 
S.E. of 
Mean(±)  
‘t’ value P value Remarks 
BT AT 
Nasal obstruction 3.1 0.95 69.35 0.72 0.16 13.44 <0.001 S 
Nasal discharge 1.95 0.95 51.28 0.97 0.22 4.5 <0.001 S 
Impairment of smell 1.3 0.6 53.85 0.73 0.16 4.37 <0.001 S 
Headache & Facial pain 0.8 0.3 62.5 0.61 0.14 3.57 <0.01 S 
Discomfort in nose 2.2 0.75 65.91 1.15 0.26 5.58 <0.001 S 
Congestion of nasal 
mucosa 
1.2 0.35 70.83 0.74 0.17 5.0 <0.001 S 
Size of inferior turbinate 
(mm) 
3.4 1.5 55.88 0.72 0.16 11.88 <0.001 S 
Effects on Nasal obstruction: The mean of Nasal 
obstruction reduced from 3.1 to 1.85 with 40.32% mean 
reduction which was statistically significant at the P value 
<0.001. Changes after 7 days of application showed that 
the mean of Nasal obstruction had reduced from 3.1 to 1.3 
with 58.06 % mean reduction which was statistically 
significant at the P value <0.001. Changes after 21 days of 
application showed that the mean of Nasal obstruction had 
reduced from 3.1 to 0.95 with 69.35 % mean reduction 
which was statistically significant at the P value <0.001. 
Effects on Nasal discharge: The mean of Nasal discharge 
reduced from 1.95 to 1.5 with 23.1% mean reduction 
which was statistically significant at the P value <0.01. 
Changes after 7 days showed that the mean of Nasal 
discharge had reduced from 1.95 to 1.15 with 41.03 % 
mean reduction which was statistically significant at the P 
value <0.001. Changes after 21 days of application showed 
that the mean of Nasal discharge had reduced from 1.95 to 
0.95 with 51.28 % mean reduction which was statistically 
significant at the P value <0.001. 
Effects on Impairment of smell: The mean of Impairment 
of smell reduced from 1.3 to 0.9 with 30.77 % mean 
reduction which was statistically significant at the P value 
<0.01. Changes after 7 days of application showed that the 
mean of Impairment of smell had reduced from 1.3 to 0.85 
with 34.62 % mean reduction which was statistically 
significant at the P value <0.01. Changes after 21 days of 
application showed that the mean of Impairment of smell 
had reduced from 1.3 to 0.6 with 53.85 % mean reduction 
which was statistically significant at the P value<0.001. 
Effects on Headache and Facial pain: The mean of 
Headache and Facial pain reduced from 0.8 to 0.7 with 
12.5 % mean reduction which was statistically not 
significant (P value>0.O5). Changes after 7 days of 
application showed that the mean of Headache and facial 
pain had reduced from 0.8 to 0.45 with 43.75 % mean 
reduction which was statistically significant at the P 
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value<0.01. Changes after 21 days of application showed 
that the mean Headache and Facial pain had reduced from 
0.8 to 0.3 with 62.5 % mean reduction which was 
statistically significant at the P value <0.01. 
Effects on Discomfort in Nose: The mean of Discomfort in 
nose reduced from 2.2 to 2.0 with 09.09% mean reduction 
which was statistically Not significant [P value >0.05]. 
Changes after 7 days of application showed that the mean 
of Discomfort in nose had reduced from 2.2 to 1.1 with 50 
% mean reduction which was statistically significant at the 
P value<0.001. Changes after 21 days of application 
showed that the mean of Discomfort in nose had reduced 
from 2.2 to 0.75 with 65.91% mean reduction which was 
statistically significant at the P value <0.001. 
Effects on Congestion of nasal mucosa and turbinate: 
The mean of Congestion of nasal mucosa and turbinate 
reduced from 1.2 to 1.15 with 04.17% mean reduction 
which was statistically Not significant [P value of >0.05]. 
Changes after 7 days of application showed that the mean 
of Congestion of nasal mucosa and turbinate had reduced 
from 1.2 to 0.45 with 62.5 % mean reduction which was 
statistically significant at the P value <0.001. Changes after 
21 days of application showed that the mean of Congestion 
of nasal mucosa and turbinate had reduced from 1.2 to 
0.35 with 70.83 % mean reduction which was statistically 
significant at the P value <0.001. 
Effects on Size of inferior turbinate: The mean of Size of 
inferior turbinate reduced from 3.4mm to 2.2 mm with 
35.29 % mean reduction which was statistically significant 
at the P value <0.001. Changes after 7 days of application 
showed that the mean of Size of inferior turbinate had 
reduced from 3.4mm to 1.85mm with 45.59 % mean 
reduction which was statistically significant at the P value 
<0.001. Changes after 21 days of application showed the 
mean of Size of inferior turbinate had reduced from 3.4 
mm to 1.5 mm with 55.88% mean reduction which was 
statistically significant at the P value <0.001. 
Effects on Overall Signs & Symptoms: In 30% patients 
no improvement was seen, in 60% patients mild 
improvement was seen, in 10% patients moderate 
improvement was seen.  
CONCLUSION 
 Nidana explained in the Ayurvedic classics seems 
to be initiating or precipitating factors for Nasapratinaha. 
Vihara Sambhandi Nidanas like exposure to dust (Raja), 
smoke (Dhooma), cold breeze (Sheetavayu) and 
Nidanarthakara Roga like Pratishyaya have significant role 
in causing Nasapratinaha. Patients of Allergic Rhinitis 
constituted the bulk of the subjects. Samprapti of 
Nasapratinaha is complex, as various known, unknown, 
exogenous, or endogenous etiological factors are involved 
in its pathogenesis. Apamarga Kshara was found to be very 
effective in reliving the severity of the disease. The results 
were encouraging to start with just after the application of 
the Ksharas, but pronounced after 7days and 21days of 
assessment. Significant improvement in features of 
Allergic Rhinitis was also seen in some patients. Results 
imply that Ksharakarma can be recognized as a potent and 
worthwhile procedure in the management of Nasal 
obstruction (Nasapratinaha) due to Hypertrophied 
Inferior Turbinates. Lifestyle modification, avoidance of 
causative factors, Yoga etc. can contribute tremendously in 
maintaining the patency of the nose. 
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